Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

immunity · Mechanism Report

Can low total IgG coexist with autoimmunity and recurrent infections?

Low total IgG can coexist with autoimmunity and can increase susceptibility to recurrent or persistent infections.

PlausibleSeptember 29, 202613 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Low total IgG can coexist with autoimmunity because impaired antibody quantity does not necessarily prevent dysregulated autoreactive B-cell responses, and reduced immunoglobulin reserve can increase susceptibility to recurrent or persistent infections that continue immune stimulation.

laying out figure…
0 of 4 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says that reduced antibody quantity does not rule out dysregulated autoreactive B-cell activity, so low IgG and autoimmunity can appear together. The mechanism framing emphasizes B-cell tolerance defects and reduced switched-memory B cells as part of this pattern, especially in CVID. It also notes that reduced immunoglobulin reserve can make infections more recurrent or persistent, which may continue immune stimulation.

Verified conclusion

Low total IgG and autoimmunity are not contradictory findings, particularly in common variable immunodeficiency (CVID), where defective humoral immunity can coexist with substantial immune dysregulation.

Clinical and mechanistic evidence

  • CVID is characterized by reduced IgG and impaired specific antibody responses, yet autoimmunity occurs in approximately 20–50% of patients across cohorts, with autoimmune cytopenias among the prominent manifestations.
  • Autoimmune CVID cohorts show increased autoreactive 9G4-positive B cells in naïve and memory compartments, supporting failures of both central and peripheral B-cell tolerance. Reduced switched-memory B cells are also associated with autoimmunity and other non-infectious CVID complications.
  • Proposed mechanisms include impaired deletion of autoreactive B cells and, in some people with TNFRSF13B/TACI variants, altered B-cell-receptor–TLR7/9 signaling. Expansion of CD21low B cells may further reflect an autoreactive/polyreactive B-cell compartment, although it is not universal or diagnostic alone.
  • Thus, low bulk immunoglobulin production does not imply absence of pathogenic autoreactive B cells. Defects in class switching, affinity maturation, activation, and plasma-cell differentiation may coexist with failed immune tolerance.

Infection and inflammatory implications

  • Low IgG is credibly associated with greater vulnerability to recurrent, severe, or persistent infection. In adults receiving rituximab for systemic autoimmune rheumatic disease, baseline IgG <6 g/L was associated with greater severe-infection risk; in transplant studies, IgG <4 g/L was associated with respiratory, CMV, and fungal infections.
  • Reduced neutralization, opsonization, complement activation, and phagocyte-mediated clearance provide a direct explanation. Persistent microbial antigen exposure can plausibly sustain innate receptor signaling and inflammatory cytokine production, although this downstream systemic effect is conditional rather than established in humans with hypogammaglobulinemia.

Bottom line

  • Low IgG can coexist with—and does not protect against—autoimmunity; it also increases infection susceptibility. Infection-driven ongoing immune stimulation is biologically plausible, while its direct contribution to systemic immune dysregulation remains less firmly demonstrated.

References

  1. Frontiers | Failure of B Cell Tolerance in CVID — frontiersin.org ↗
  2. Common variable immunodeficiency disorders - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  3. Common Variable Immunodeficiency and Autoimmune ... — pmc.ncbi.nlm.nih.gov ↗
  4. CVID-associated TACI mutations affect autoreactive B cell selection ... — jci.org ↗
  5. Autoimmune Cytopenias In Common Variable Immunodeficiency — ncbi.nlm.nih.gov ↗
  6. [PDF] Practical guidance for the diagnosis and management of secondary ... — aaaai.org ↗
  7. [PDF] Recommendations for Management of Secondary Antibody ... - -ORCA — orca.cardiff.ac.uk ↗
  8. Evidence‐ and Consensus‐Based Recommendations for the ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  9. Evidence‐ and Consensus‐Based Recommendations for the ... — onlinelibrary.wiley.com ↗
  10. Frontiers | The Expanding Field of Secondary Antibody Deficiency: Causes, Diagnosis, and Management — frontiersin.org ↗
  11. Frontiers | Non-infectious Complications of Common Variable Immunodeficiency: Updated Clinical Spectrum, Sequelae, and Insights to Pathogenesis — frontiersin.org ↗
  12. Autoimmunity in Common Variable Immunodeficiency - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  13. Diagnosis and Management of Antibody Immunodeficiencies — discovery.ucl.ac.uk ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible14 sourcesCan suboptimal vitamin D reduce immune regulation?→Plausible8 sourcesIs food allergy an immune reaction distinct from the TMAO pathway?→